ClinTec GmbH CEO, Dr Rabinder Buttar Named Female Business Leader of the Year at the Scottish Leadership 2010 Awards
Published: Oct 08, 2010
Others in the award category included Michelle Mone, founder and co-owner of MJM International and Audrey Baxter, Executive Chairman of Baxters, the international food company.
The award ceremony was held at the Grand Central Hotel in Glasgow with Lord Ashdown present as guest speaker.
Dr Buttar was recognised by the Scottish Leadership Awards for her unique business acumen and entrepreneurial spirit in building one of Britain’s fastest growing privately owned tech companies; 27th in the league of top 100 companies in Britain - Sunday Times Microsoft Tech Track 100.
On winning the award, Dr Buttar stated: “I am honored to receive this award and see it as a great reflection not just of my work but that of our Senior Corporate Director, Bobby Bal and the experienced global management team supporting me. Leadership is about motivating people and bringing out the best in them to deliver challenging company goals. I am proud to have created an organisation in which employees based in Scotland plus 40 countries globally are passionate about their work and have an uncompromising attitude to deliver nothing short of excellence in all they do for our pharmaceutical and biotech clients.”
This recognition by the Scottish Leadership is one of several awards that ClinTec and Dr Buttar have been nominated for during the final quarter of 2010, including being shortlisted for the Pharma industry’s SCRIP Awards as the best Contract Research Organisation of the Year 2010.”
About ClinTec International
ClinTec is a global contract clinical research organisation, established in 1997 by Dr Rabinder Buttar, the company’s President and CEO. ClinTec has a presence in over 40 developed and emerging countries, covering Western Europe, Central & Eastern Europe, the Middle East and North Africa, Central and South Africa, Latin America, India and the US.
In addition to ClinTec’s vast expertise in oncology, the organisation has also conducted over 400 clinical trials in other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology. ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world-class project managers and clinical research associates. ClinTec’s fast, flexible and focused approach to clinical research ensures an added advantage to the drug development process. The organisations range of services includes Clinical Monitoring and Project Management, Regulatory Affairs, Medical Writing, Data Management and Biostatistics, Global Clinical Resourcing, Quality Assurance, Drug Development Consultancy and Clinical Training courses.
For further information please contact:
Bobby Bal, Senior Director Corporate Development, ClinTec International Headquarters: +44 (0) 141 226 1120 or email@example.com
For more information about ClinTec, please visit www.clintec.com
For media enquiries, please contact Tristan Jervis/Alex Heeley on: 00 44 207 861 3019 or e-mail: firstname.lastname@example.org.